These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Importance of corneal saturation time with riboflavin prior to collagen cross-linking. Samarawickrama C; Chan E; Loughnan M; Snibson GR Clin Exp Ophthalmol; 2016 Apr; 44(3):196-7. PubMed ID: 26433126 [No Abstract] [Full Text] [Related]
3. Biomechanical parameters of the cornea after collagen crosslinking measured by waveform analysis. Sedaghat M; Naderi M; Zarei-Ghanavati M J Cataract Refract Surg; 2010 Oct; 36(10):1728-31. PubMed ID: 20870120 [TBL] [Abstract][Full Text] [Related]
4. Riboflavin/UVA cross-linking for keratoconus in Down syndrome. Koppen C; Leysen I; Tassignon MJ J Refract Surg; 2010 Sep; 26(9):623-4. PubMed ID: 20839768 [No Abstract] [Full Text] [Related]
14. Remodeling effect of cross-linking. Orucoglu Orucov F; Kaya V J Refract Surg; 2009 Dec; 25(12):1051; author reply 1051-2. PubMed ID: 20000284 [No Abstract] [Full Text] [Related]
15. Pachymetry during Cross-linking. Tahzib NG; Van der Lelij A Ophthalmology; 2010 Oct; 117(10):2041, 2041.e1; author reply 2041-2. PubMed ID: 20888486 [No Abstract] [Full Text] [Related]
16. Riboflavin/Ultraviolet A corneal collagen cross-linking for the treatment of keratoconus: visual outcomes and Scheimpflug analysis. Henriquez MA; Izquierdo L; Bernilla C; Zakrzewski PA; Mannis M Cornea; 2011 Mar; 30(3):281-6. PubMed ID: 21045662 [TBL] [Abstract][Full Text] [Related]
17. Corneal Cross-linking for Keratoconus: A Look at the Data, the Food and Drug Administration, and the Future. Jeng BH; Farid M; Patel SV; Schwab IR Ophthalmology; 2016 Nov; 123(11):2270-2272. PubMed ID: 27772645 [No Abstract] [Full Text] [Related]